Leadership

HSCI is led by faculty directors Doug Melton and David Scadden, and executive director Brock Reeve, all of whom are appointed by the provost of Harvard University.

They are guided by an Executive Committee composed of leaders across Harvard schools and teaching hospitals. Their combined expertise in both science and business provides HSCI with the essential ‘intellectual venture capital’ to guide our strategy, shape our programs, and ensure stem cell research across Harvard can be harnessed for patient benefit.

HSCI Scientific Directors

David Scadden, Harvard Stem Cell institute

David Scadden, M.D.

Harvard Department of Stem Cell and Regenerative Biology
Massachusetts General Hospital

HSCI Executive Director

HSCI Executive Committee

Jerry Ritz photo credit Dana-Farber Cancer Institute

Jerome Ritz, M.D.

Dana-Farber Cancer Institute
Brigham and Women's Hospital
Harvard Medical School
Lee Rubin headshot image

Lee L. Rubin, Ph.D.

Harvard Department of Stem Cell and Regenerative Biology
Principal Faculty, Harvard Stem Cell Institute
Co-chair, HSCI Nervous System Disease Program
David Scadden, Harvard Stem Cell institute

David Scadden, M.D.

Harvard Department of Stem Cell and Regenerative Biology
Massachusetts General Hospital
Photo of Amy Wagers

Amy Wagers, Ph.D.

Co-chair, Harvard Department of Stem Cell and Regenerative Biology
Senior Investigator, Islet Cell and Regenerative Biology, Joslin Diabetes Center
Photo of Leonard Zon, M.D.

Leonard I. Zon, M.D.

Harvard Department of Stem Cell and Regenerative Biology
Boston Children's Hospital
Harvard Medical School

HSCI Faculty

Our faculty represent a broad range of disciplines, from bioengineering to neurology and oncology. HSCI brings them together to share knowledge, exchange best practice, and explore bold, new ideas together.
 

Meet our Faculty